Case Report: Dynamic TKI combination strategies for EGFR-mutant NSCLC with acquired ROS1 fusion and brain metastases - Top-Institutions - MDSpire

Case Report: Dynamic TKI combination strategies for EGFR-mutant NSCLC with acquired ROS1 fusion and brain metastases

  • By

  • Hua Yang

  • Yong Da

  • Ge Shen

  • Qi-Yun Sun

  • Zhi-Yu Yao

  • Ya-Jing Zhou

  • June 4, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    School of Medicine
    School of Medicine

    Richmond, Virginia

    Key Differentiators

    • Oncology

  • #2

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, France

    Key Differentiators

    • Oncology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #4

    The First Affiliated Hospital of Guangzhou Medical University
    The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, China

    Key Differentiators

    • Oncology

  • #5

    National Clinical Research Centre for Respiratory Disease
    National Clinical Research Centre for Respiratory Disease

    Beijing, China

    Key Differentiators

    • Oncology

Original Source(s)

Case Report: Dynamic TKI combination strategies for EGFR-mutant NSCLC with acquired ROS1 fusion and brain metastases

  • by Hua Yang, Yong Da, Ge Shen, Qi-Yun Sun, Zhi-Yu Yao, Ya-Jing Zhou

  • June 4, 2026

Related Content

Predicting survival in oral squamous cell carcinoma via integrated analysis of tumor budding and tertiary lymphoid structures

Incidence and Survival of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms in the Contemporary Era

Mechanisms and biomarkers of immune checkpoint inhibitor-associated myocarditis: from T cell imbalance to multicellular crosstalk